beta
ZNTL
Zentalis Pharmaceuticals Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer
Market Cap: 1.03 Billion
Primary Exchange: NASDAQ
Website: zentalis.com
Shares Outstanding: 71 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.607413276195365
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 373 trading days
From: 2020-06-25 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|